Concepedia

Richard Klar

RK

16

Publications

1.2K

Citations

13

H-Index

2012

Active since

Affiliations

Hikma Pharmaceuticals (Germany)(Current)

Technical University of Munich

Klinikum rechts der Isar

Heidelberg University

Deutschen Konsortium für Translationale Krebsforschung

Richard Klar is an author at Hikma Pharmaceuticals (Germany) specializing in medicine, immunotherapy, and hematology.

ORCID

Top concepts

Publications per year

2012–2023

16

Publications

16

Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry

Michal Bassani‐Sternberg, Eva Bräunlein, Richard Klar et al. · Nature Communications · 2016 · 698 citations · Full text

ER stress-induced mediator C/EBP homologous protein thwarts effector T cell activity in tumors through T-bet repression

Yu Cao, Jimena Trillo-Tinoco, Rosa A. Sierra et al. · Nature Communications · 2019 · 150 citations · Full text

Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity

Abhishek S. Kashyap, Tamara Thelemann, Richard Klar et al. · Journal for ImmunoTherapy of Cancer · 2019 · 59 citations · Full text

Immuno-PET Imaging of Engineered Human T Cells in Tumors

Sabine Mall, Nahid Yusufi, Ricarda Wagner et al. · Cancer Research · 2016 · 56 citations

Therapeutic Targeting of Metadherin Suppresses Colorectal and Lung Cancer Progression and Metastasis

Minhong Shen, Shanshan Xie, Michelle Rowicki et al. · Cancer Research · 2020 · 50 citations · Full text

Rows per page

1–5 of 16